XML 30 R8.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2022
Cash flows from operating activities:      
Net income $ 39,634 $ 15,659 $ 15,651
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 71,485 67,960 75,449
Provision for credit losses 2,162 629 1,396
Stock-based compensation, excluding cash-settled awards 67,622 76,051 65,246
Change in fair value of future tranche right 0 0 (15,810)
Benefit from deferred income taxes (17,639) (9,544) (11,323)
Non-cash losses on derivative financial instruments, net 0 0 14,374
Losses on early retirements of debt 237 0 2,474
Net losses on divested businesses 9,541 0 0
Other non-cash items, net 5,347 9,652 7,416
Changes in operating assets and liabilities, net of effects of business combinations and divestitures:      
Accounts receivable (9,409) 3,060 11,712
Contract assets (6,351) (18,762) (6,391)
Inventories (1,812) (7,753) (713)
Prepaid expenses and other assets 35,027 (44,247) (33,107)
Accounts payable and accrued expenses (25,343) 6,394 (1,772)
Contract liabilities (26,068) 5,395 7,820
Other liabilities 13,762 40,852 (2,321)
Other, net (7,553) (5,530) 4,553
Net cash provided by operating activities — continuing operations 150,642 139,816 134,654
Net cash used in operating activities — discontinued operations 0 0 (9,055)
Net cash provided by operating activities 150,642 139,816 125,599
Cash flows from investing activities:      
Cash paid for business combinations, including adjustments, net of cash acquired (3,997) (21,928) (57,024)
Divestitures, net of cash divested (6,278) 0 0
Purchases of property and equipment (16,114) (27,950) (16,962)
Purchases of investments (4,094) (10,627) (751)
Maturities and sales of investments 4,083 10,709 46,299
Cash paid for capitalized software development costs (9,623) (7,595) (7,560)
Other investing activities (1,356) 808 98
Net cash used in investing activities (37,379) (56,583) (35,900)
Cash flows from financing activities:      
Proceeds from issuance of preferred stock and future tranche right, net of issuance costs 0 0 198,731
Proceeds from borrowings 100,000 0 315,000
Repayments of borrowings and other financing obligations (103,084) (3,658) (313,354)
Settlement of 2014 Notes 0 0 (386,887)
Purchases of capped calls 0 0 (41,060)
Payments of equity issuance, debt issuance, and other debt-related costs (232) (224) (10,708)
Distributions paid to noncontrolling interest (766) (787) (1,110)
Purchases of treasury stock and common stock for retirement (124,290) (128,985) (75,955)
Preferred stock dividend payments (20,800) (20,800) (12,856)
Payment for termination of interest rate swap 0 0 (16,502)
Net cash transferred to Cognyte Software Ltd. 0 0 (114,657)
Dividend and other settlements received from Cognyte Software Ltd. 0 0 38,280
Payments of contingent consideration for business combinations (financing portion) and other financing activities (4,182) (3,453) (9,045)
Net cash used in financing activities (153,354) (157,907) (430,123)
Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents 599 (2,033) (841)
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents (39,492) (76,707) (341,265)
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of year 282,161 358,868 700,133
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of year $ 242,669 $ 282,161 $ 358,868